Blueprint Medicines Corporation BPMC
129.46 0.00 (+0.00%)
At closeJul 18, 2025, 4:00 PM EDT
129.46 Day range 129.46
52-week range unavailable
- YTD
- +48.43%
- 1 year
- +13.20%
Revenue & Expenses
Latest period ending Dec 31, 2024 · select a line to chart its full history
Income statement
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 508.82M | 249.38M | 204.04M | 180.08M | 793.74M | |
| 488.66M | 236.58M | 177.28M | 154.34M | 793.31M | |
| -212.04M | -486.28M | -537.52M | -641.98M | 308.71M | |
| -67.09M | -506.98M | -557.52M | -644.09M | 313.88M | |
| -1.07 | -8.37 | -9.35 | -11.01 | 5.59 |
Balance sheet
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 113.64M | 81.52M | 124.90M | 215.12M | 689.80M | |
| 1.18B | 1.05B | 1.35B | 1.25B | 1.72B | |
| 881.15M | 918.64M | 835.23M | 281.49M | 248.31M | |
| 724.28M | 774.12M | 672.78M | 111.41M | 89.60M | |
| 298.67M | 130.61M | 514.68M | 970.74M | 1.47B |
Cash flow
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| -192.59M | -436.85M | -502.28M | -298.65M | 387.04M | |
| -47.50M | 274.04M | -149.54M | -225.86M | -434.25M | |
| 273.11M | 119.22M | 561.81M | 50.72M | 617.76M | |
| -4.63M | -16.06M | -8.92M | -3.09M | -3.16M | |
| 33.02M | -43.58M | -90.01M | -473.80M | 570.54M |